HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthony J Williams Selected Research

conotoxin GV

9/2005Effects of delayed intrathecal infusion of an NMDA receptor antagonist on ischemic injury and peri-infarct depolarizations.
5/2002Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anthony J Williams Research Topics

Disease

14Brain Injuries (Brain Injury)
11/2009 - 04/2002
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2009 - 04/2002
5Brain Ischemia (Cerebral Ischemia)
12/2009 - 05/2002
5Infarction (Infarctions)
12/2009 - 09/2002
5Seizures (Absence Seizure)
12/2009 - 04/2002
5Ischemia
08/2009 - 04/2002
4Inflammation (Inflammations)
07/2007 - 09/2002
2Brain Infarction
05/2004 - 04/2002
1Neoplasm Metastasis (Metastasis)
11/2015
1Breast Neoplasms (Breast Cancer)
11/2015
1Wounds and Injuries (Trauma)
08/2009
1Renal Insufficiency (Renal Failure)
06/2008
1Vasculitis (Vasculitides)
06/2008
1Purpura
06/2008
1Crystalluria
05/2008
1Necrosis
05/2008
1Hypoglycemia (Reactive Hypoglycemia)
05/2007
1Hypoxia (Hypoxemia)
05/2007
1Neoplasms (Cancer)
07/2006
1Paralysis (Palsy)
09/2005
1Cerebral Infarction
09/2005
1Body Weight (Weight, Body)
05/2005
1Chronic Kidney Failure (Chronic Renal Failure)
07/2004
1Encephalitis (Encephalitis, Rasmussen)
05/2004
1Gliosis
01/2003
1Neurologic Manifestations (Neurological Manifestations)
01/2003

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
11/2015 - 09/2008
4Proteins (Proteins, Gene)FDA Link
08/2009 - 07/2006
3Pharmaceutical PreparationsIBA
01/2008 - 09/2005
3Proteasome InhibitorsIBA
07/2006 - 01/2003
3NF-kappa B (NF-kB)IBA
07/2006 - 09/2002
3Neuroprotective AgentsIBA
10/2003 - 04/2002
2Glutamic Acid (Glutamate)FDA Link
12/2009 - 05/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
07/2006 - 01/2003
2conotoxin GVIBA
09/2005 - 05/2002
2Transcription Factors (Transcription Factor)IBA
09/2004 - 09/2002
2Messenger RNA (mRNA)IBA
05/2004 - 09/2002
2Sodium Channel BlockersIBA
10/2003 - 04/2002
2RS100642IBA
10/2003 - 04/2002
1Complement System Proteins (Complement)IBA
11/2015
1glycyl-prolyl-glutamic acidIBA
12/2009
1NNZ 2566IBA
12/2009
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
11/2009
1member 1 small inducible cytokine subfamily EIBA
08/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2008
1MethylprednisoloneFDA LinkGeneric
06/2008
1Prednisolone (Predate)FDA LinkGeneric
06/2008
1SteroidsIBA
06/2008
1Orlistat (Xenical)FDA Link
05/2008
1Calcium OxalateIBA
05/2008
1Topiramate (Topamax)FDA LinkGeneric
01/2008
14-O-carboxymethylascochlorinIBA
07/2007
1SilverIBA
07/2007
1StaurosporineIBA
05/2007
1VeratridineIBA
05/2007
1Ethosuximide (Zarontin)FDA LinkGeneric
09/2006
1Gabapentin (Neurontin)FDA LinkGeneric
09/2006
1UbiquitinIBA
07/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2005
1Peptides (Polypeptides)IBA
09/2005
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
05/2005
1antineoplaston A10 (A 10)IBA
05/2005
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2004
1DNA (Deoxyribonucleic Acid)IBA
09/2004
1Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2004
1ConvulsantsIBA
02/2003
1CytokinesIBA
09/2002
1N-Methylaspartate (NMDA)IBA
05/2002
1Mexiletine (Mexitil)FDA LinkGeneric
04/2002

Therapy/Procedure

4Treatment Delay
12/2009 - 01/2003
3Therapeutics
08/2009 - 05/2004
1Electrodes (Electrode)
09/2005
1Catheters
09/2005
1Renal Dialysis (Hemodialysis)
07/2004